Dose adjustment in renal impairment
Dose adjustment may be needed in kidney disease.
Leaflet DIGOXINA ZENTIVA 0.25mg tablets
Precautions:
Narrow therapeutic index
The dose must be followed strictly.
Additional monitoring
This medicine is subject to additional monitoring.
Requires periodic laboratory tests
Periodic laboratory tests may be required during treatment.
Cardiac risk / QT prolongation / arrhythmias
This medicine may increase the risk of heart rhythm disturbances.
Digoxin is a medication used to treat heart failure and certain types of arrhythmias, such as atrial fibrillation and atrial flutter. It belongs to the class of cardiac glycosides and works by increasing the force of heart contractions (positive inotropic effect) and slowing the heart rate (negative chronotropic effect), thereby improving the efficiency of heart function.
It is available in the form of tablets, oral solution, or injectable solution, with the dosage adjusted based on the patient's condition, kidney function, and serum digoxin levels.
Side effects may include nausea, vomiting, diarrhea, loss of appetite, dizziness, confusion, visual disturbances (such as halos or blurred vision), and arrhythmias. Digoxin toxicity is a serious complication and is more likely to occur in patients with kidney impairment or electrolyte imbalances (such as hypokalemia).
Digoxin is contraindicated in cases of ventricular fibrillation, complete atrioventricular block without a pacemaker, or hypersensitivity to the drug. Patients should be closely monitored, and serum digoxin levels should be checked regularly to prevent toxicity.
It is available in the form of tablets, oral solution, or injectable solution, with the dosage adjusted based on the patient's condition, kidney function, and serum digoxin levels.
Side effects may include nausea, vomiting, diarrhea, loss of appetite, dizziness, confusion, visual disturbances (such as halos or blurred vision), and arrhythmias. Digoxin toxicity is a serious complication and is more likely to occur in patients with kidney impairment or electrolyte imbalances (such as hypokalemia).
Digoxin is contraindicated in cases of ventricular fibrillation, complete atrioventricular block without a pacemaker, or hypersensitivity to the drug. Patients should be closely monitored, and serum digoxin levels should be checked regularly to prevent toxicity.
General data about DIGOXINA ZENTIVA 0.25mg
- Substance:
- digoxin
- Date of latest medicines list:
- 01-06-2026
- Product code:
- W58535002
- Concentration:
- 0.25mg
- Pharmaceutical form:
- tablets
- Quantity:
- 25
- Product type:
- Generic medicine
- Price:
- 30.44 RON
- Prescription status:
- P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.
Pharmaceutical forms available for digoxin
Concentrations available for digoxin
- 0.05mg/ml
- 0.25mg
- 0.25mg/ml
- 0.5mg/2ml
- 0.5mg/ml
Compensation lists for DIGOXINA ZENTIVA 0.25mg Zentiva
A - Sublist A with 90% discount from the reference price
- Price
- 30.44 RON
- Copayment
- 27.40 RON
- Patient
- 3.04 RON
G1 (C1) - Chronic heart failure (NYHA class III or IV)
- Price
- 30.44 RON
- Copayment
- 30.44 RON
- Patient
- 0.00 RON
GX (C1) - GENERIC (used in compensation list, C1, for another diagnosis)
- Price
- 30.44 RON
- Copayment
- 30.44 RON
- Patient
- 0.00 RON